BETAHISTINE-AS betahistine dihydrochloride 16mg tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

betahistine dihydrochloride, Quantity: 16 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

betahistine dihydrochloride

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; stearic acid; lactose monohydrate; povidone; crospovidone

Mode d'administration:

Oral

Unités en paquet:

10 tablets, 100 tablets, 25 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Descriptif du produit:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-11-10